Latest news
LigaChem Gains Sole Control of B7-H4 Cancer Drug With Distinct Tumor-Killing Mechanism - Tech TimesTech Times · Fri, 07 Aug 2026 18:29:26 GMTLigaChem Biosciences Takes Solo Control of ADC Cancer Drug After NextCure's Strategic Pivot - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 06:05:00 GMTLigachem Biosciences takes sole control of ADC LNCB74, pursues global licensing - CHOSUNBIZ - ChosunbizChosunbiz · Fri, 07 Aug 2026 02:15:00 GMTFrom licensing deals to patients: LigaChem and ABL Bio shift focus to clinical proof - koreabiomed.comkoreabiomed.com · Wed, 05 Aug 2026 07:12:03 GMTETFs Investing in LigaChem Biosciences Inc. Stocks - TradingViewTradingView · Sat, 01 Aug 2026 06:22:44 GMTLigaChem Biosciences wins third US ADC trial nod with ExoThera’s IKS04 - CHOSUNBIZ - ChosunbizChosunbiz · Fri, 31 Jul 2026 07:00:00 GMT